Eric Klein, MD, Chairman of Cleveland Clinic’s Glickman Urological & Kidney Institute joins the Cancer Advances podcast to discuss the IsoPSA Test, now being offered at Cleveland Clinic. The IsoPSA test is a novel prostate-specific antigen assay for patients with a PSA > 4ng/ml who are facing a decision on prostate biopsy. Listen as Dr. Klein discusses how the IsoPSA test differs from conventional PSA testing and how your patients can benefit.
view more